Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs among large drugmakers
Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs [...]
Leo Pharma gains FDA nod for eczema drug Adbry, but can it challenge Sanofi and Regeneron’s formidable Dupixent?
Leo Pharma gains FDA nod for eczema drug Adbry, but [...]
Merck, Ridgeback clinch FDA’s 2nd emergency nod for a COVID-19 antiviral pill
Merck, Ridgeback clinch FDA’s 2nd emergency nod for a COVID-19 [...]
Pfizer’s megablockbuster-to-be COVID pill Paxlovid scores FDA nod
Pfizer’s megablockbuster-to-be COVID pill Paxlovid scores FDA nod esagonowsky Wed, [...]
Biogen, Eisai face down another Aduhelm refusal—this time from Japanese regulators
Biogen, Eisai face down another Aduhelm refusal—this time from Japanese [...]
Particulate problem prompts hold on 10 Gilead studies of HIV hopeful lenacapavir
Particulate problem prompts hold on 10 Gilead studies of HIV [...]
With Sanofi’s mighty Dupixent chasing behind, Takeda’s Eohilia suffers FDA rejection after mysterious delay
With Sanofi’s mighty Dupixent chasing behind, Takeda’s Eohilia suffers FDA [...]
Girding for BMS competition, Amgen wins another plaque psoriasis nod for Otezla
Girding for BMS competition, Amgen wins another plaque psoriasis nod [...]
Eli Lilly finds embarrassment main cause of underreporting of symptoms in ulcerative colitis
Eli Lilly finds embarrassment main cause of underreporting of symptoms [...]
GlaxoSmithKline reveals health fears of eosinophilic asthma patients, frustration of late diagnosis
GlaxoSmithKline reveals health fears of eosinophilic asthma patients, frustration of [...]